• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

关于新冠病毒mRNA疫苗的评论

Commentary of the mRNA vaccines COVID-19.

作者信息

Vitiello Antonio, Ferrara Francesco

机构信息

Pharmaceutical Department, Usl Umbria 1, Perugia 06132, Italy.

出版信息

Asian J Pharm Sci. 2021 Sep;16(5):531-532. doi: 10.1016/j.ajps.2021.05.004. Epub 2021 Jul 2.

DOI:10.1016/j.ajps.2021.05.004
PMID:34849160
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8609436/
Abstract

Image, graphical abstract.

摘要

图像，图形摘要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ee6/8609436/57a83e15665a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ee6/8609436/c9f7f3186806/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ee6/8609436/57a83e15665a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ee6/8609436/c9f7f3186806/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ee6/8609436/57a83e15665a/gr1.jpg

相似文献

1
Commentary of the mRNA vaccines COVID-19.关于新冠病毒mRNA疫苗的评论
Asian J Pharm Sci. 2021 Sep;16(5):531-532. doi: 10.1016/j.ajps.2021.05.004. Epub 2021 Jul 2.
2
SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in U.S. FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System.美国 FDA 公开意见中表达的对 SARS-CoV-2 mRNA 疫苗的态度：在学习型免疫接种系统中建立公私伙伴关系的必要性。
Front Public Health. 2021 Jul 16;9:695807. doi: 10.3389/fpubh.2021.695807. eCollection 2021.
3
Advances of mRNA vaccines for COVID-19: A new prophylactic revolution begins.新冠病毒mRNA疫苗的进展：一场新的预防性革命拉开帷幕。
Asian J Pharm Sci. 2021 May;16(3):263-264. doi: 10.1016/j.ajps.2021.02.005. Epub 2021 Mar 22.
4
Positive aspects of the mRNA platform for SARS-CoV-2 vaccines.mRNA 平台在 SARS-CoV-2 疫苗方面的积极方面。
Hum Vaccin Immunother. 2021 Aug 3;17(8):2445-2447. doi: 10.1080/21645515.2021.1900713. Epub 2021 Apr 8.
5
The COVID-19 mRNA Vaccines and the Pandemic: Do They Represent the Beginning of the End or the End of the Beginning?《COVID-19 mRNA 疫苗与大流行：它们代表着结束的开始还是开始的结束？》
Clin Ther. 2021 Mar;43(3):549-556. doi: 10.1016/j.clinthera.2021.01.014. Epub 2021 Jan 22.
6
Family Physicians' Perception of the New mRNA COVID-19 Vaccines.家庭医生对新型 mRNA COVID-19 疫苗的看法。
J Am Board Fam Med. 2021 Sep-Oct;34(5):898-906. doi: 10.3122/jabfm.2021.05.210052.
7
Commentary: Strategies to Address COVID-19 Vaccine Hesitancy and Mitigate Health Disparities in Minority Populations.评论：应对新冠疫苗犹豫情绪及缓解少数族裔健康差异的策略
Front Public Health. 2021 Jul 29;9:723583. doi: 10.3389/fpubh.2021.723583. eCollection 2021.
8
Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS).接种 mRNA COVID-19 疫苗后出现的血小板减少症，包括免疫性血小板减少症，已向疫苗不良事件报告系统（VAERS）报告。
Vaccine. 2021 Jun 8;39(25):3329-3332. doi: 10.1016/j.vaccine.2021.04.054. Epub 2021 Apr 30.
9
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.mRNA COVID-19 疫苗接种后出现心肌炎报告：免疫实践咨询委员会更新-美国，2021 年 6 月。
MMWR Morb Mortal Wkly Rep. 2021 Jul 9;70(27):977-982. doi: 10.15585/mmwr.mm7027e2.
10
Factors Affecting Hesitancy to mRNA and Viral Vector COVID-19 Vaccines among College Students in Italy.影响意大利大学生对mRNA和病毒载体新冠疫苗接种犹豫的因素
Vaccines (Basel). 2021 Aug 19;9(8):927. doi: 10.3390/vaccines9080927.

引用本文的文献

1
Lipid-based Non-viral Vector: Promising Approach for Gene Delivery.基于脂质的非病毒载体：基因递送的有前景方法。
Curr Pharm Des. 2025;31(7):521-539. doi: 10.2174/0113816128324084240828084904.
2
Ionizable drug delivery systems for efficient and selective gene therapy.用于高效和选择性基因治疗的可离子化药物传递系统。
Mil Med Res. 2023 Feb 27;10(1):9. doi: 10.1186/s40779-023-00445-z.
3
The global mRNA vaccine patent landscape.全球 mRNA 疫苗专利全景图。

本文引用的文献

1
Acute Allergic Reactions to mRNA COVID-19 Vaccines.mRNA COVID-19 疫苗的急性过敏反应。
JAMA. 2021 Apr 20;325(15):1562-1565. doi: 10.1001/jama.2021.3976.
2
Drugs acting on the renin-angiotensin system and SARS-CoV-2.作用于肾素-血管紧张素系统的药物与 SARS-CoV-2。
Drug Discov Today. 2021 Apr;26(4):870-874. doi: 10.1016/j.drudis.2021.01.010. Epub 2021 Jan 21.
3
Efficacy of synthetic glucocorticoids in COVID-19 endothelites.合成糖皮质激素在新型冠状病毒肺炎内皮病变中的疗效
Hum Vaccin Immunother. 2022 Nov 30;18(6):2095837. doi: 10.1080/21645515.2022.2095837. Epub 2022 Jul 7.
Naunyn Schmiedebergs Arch Pharmacol. 2021 May;394(5):1003-1007. doi: 10.1007/s00210-021-02049-7. Epub 2021 Jan 14.
4
Remdesivir and COVID-19 infection, therapeutic benefits or unnecessary risks?瑞德西韦与新冠病毒感染：治疗益处还是不必要的风险？
Ir J Med Sci. 2021 Nov;190(4):1637-1638. doi: 10.1007/s11845-020-02482-2. Epub 2021 Jan 12.
5
COVID-19 Vaccines May Not Prevent Nasal SARS-CoV-2 Infection and Asymptomatic Transmission.COVID-19 疫苗可能无法预防鼻腔 SARS-CoV-2 感染和无症状传播。
Otolaryngol Head Neck Surg. 2021 Feb;164(2):305-307. doi: 10.1177/0194599820982633. Epub 2020 Dec 15.
6
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
7
Correlation between the use of statins and COVID-19: what do we know?他汀类药物的使用与2019冠状病毒病之间的关联：我们了解什么？
BMJ Evid Based Med. 2022 Apr;27(2):126-127. doi: 10.1136/bmjebm-2020-111589. Epub 2020 Dec 2.
8
Remdesivir versus ritonavir/lopinavir in COVID-19 patients.瑞德西韦与利托那韦/洛匹那韦用于新冠肺炎患者的对比
Ir J Med Sci. 2021 Aug;190(3):1249-1250. doi: 10.1007/s11845-020-02440-y. Epub 2020 Nov 18.
9
Vaccines against COVID-19.针对新型冠状病毒肺炎的疫苗。
Anaesth Crit Care Pain Med. 2020 Dec;39(6):703-705. doi: 10.1016/j.accpm.2020.10.006. Epub 2020 Oct 20.
10
Remdesivir and COVID-19.瑞德西韦与新型冠状病毒肺炎
Ir J Med Sci. 2021 Aug;190(3):1237-1238. doi: 10.1007/s11845-020-02401-5. Epub 2020 Oct 17.